Council Members in this Study Group: 1362
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Dan StrejaClinical Professor of Medicine
UNIVERSITY OF CALIFORNIA, LOS ANGELES![]()
Dan Streja, MD, is Clinical Professor of Medicine at the University of California, Los Angeles. He is also Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic, the Diabetes Clinic, and the divisions of Cardiology and Endocrinology at...
Clinical Director
NEW YORK UNIVERSITY (INC)![]()
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub...
Charles GlueckDirector of Cholesterol Center
Jewish Hospital![]()
Charles Glueck, MD, is the Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, atherosclerosis-thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology and hematology. Dr....
Director of Clinical Pharmacology
THE UNIVERSITY OF IOWA![]()
William Haynes, MD, is Professor of Medicine and Director of Clinical Pharmacology at the University of Iowa. Dr. Haynes has expertise in cardiovascular risk factors including diabetes, hypertension, hyperlipidemia, obesity, and atherosclerosis. He has...
Harold BaysPresident and Medical Director
L-MARC Research Center![]()
Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all...
May 22, 2008 | Boston
GLG Seminar: Diabetes and ObesityMarch 28, 2008 | Boston
GLGi: Lipid ManagementJune 20, 2007 | Chicago
GLGi: Diabetes and ObesityTeleconference: Weight Loss - Lorcaserin Out (For Now), Qnexa Up at Bat (12:00 PM EDT/17:00 BST)
10/27/2010